APA (7th ed.) Citation

Mavratzas, A., Seitz, J., Smetanay, K., Schneeweiss, A., Jäger, D., & Fremd, C. (2020). Atezolizumab for use in PD-L1-positive unresectable, locally advanced or metastatic triple-negative breast cancer. Future oncology, 16(3), . https://doi.org/10.2217/fon-2019-0468

Chicago Style (17th ed.) Citation

Mavratzas, Athanasios, Julia Seitz, Katharina Smetanay, Andreas Schneeweiss, Dirk Jäger, and Carlo Fremd. "Atezolizumab for Use in PD-L1-positive Unresectable, Locally Advanced or Metastatic Triple-negative Breast Cancer." Future Oncology 16, no. 3 (2020). https://doi.org/10.2217/fon-2019-0468.

MLA (9th ed.) Citation

Mavratzas, Athanasios, et al. "Atezolizumab for Use in PD-L1-positive Unresectable, Locally Advanced or Metastatic Triple-negative Breast Cancer." Future Oncology, vol. 16, no. 3, 2020, https://doi.org/10.2217/fon-2019-0468.